| |
Clinical
Research |
| |
 |
Neeman Medical International
Every
drug used for diagnostic, preventive or therapeutic purpose
undergoes a very long and rigorous testing processes stretched
over a period of 10 to 15 years. During this time, it is tested
extensively, to gauge its efficacy and safety in preventing
and treating diseases. A look at the global drug development
map reveals that the majority of drug discoveries are credited
to pharma majors based in the West. Consequently, the knowledge
related to drug development processes and clinical practices
have largely remained confined to that part of the world.
However, as a result of increasingly stringent regulatory
procedures, the cost of developing a new drug has gone up
from US$ 500 million to approximately US$ 700 million over
the last five years. At the same time, India has earned the
world's attention due to the growing strength of her pharmaceuticals
industry and vast pool of internationally recognized medical
professionals. In addition to the above, the healthcare necessities
of a billion strong population and limited access to state-of-the-art
treatment have highlighted the potential India holds for participating
in global clinical trials to evaluate new drugs. In recognition
of these factors, the evolving regulatory mechanism, and ethical
requirements of clinical research conforming to international
standards, Max set up India's first multinational study conduct
organization.
|
Neeman
Medical International's mission is to provide the pharmaceutical
industry with cost effective means of evaluating new
drugs in a reliable and timely manner and ensure the
availability of drugs to patients. This effort will
bring global pharma majors to India and help Neeman
offer its various overseas locations to major Indian
pharmaceutical companies for the evaluation of their
drugs.
|
|
|
|
Neeman's
Global Presence
Headquartered near Research Triangle Park, in Cary,
North Carolina, U.S.A., Neeman has set up regional
hubs all across the globe to ensure accessibility
to quality Clinical Research centers in Asia, Latin
America and Europe to international pharmaceutical
companies. Neeman Medical International (Asia) is
the Indian hub based in Delhi and has a regional center
in Mumbai. Neeman's global reach extends from the
Pacific Rim to the Indian Ocean, from Europe to Asia
and Latin America. Other hubs include Neeman-Europe based
in Ireland.
|
Neeman
Medical Internal (Asia): Leadership position through unique
advantages
Neeman
Asia :
- Is
the first Indian multinational study conduct organization
- Has
extensive experience with the Indian regulatory agency
- Has
an extensive network of 450 researchers specialized in various
therapeutic areas with a patient database of over 35,000.
Most are trained in Good Clinical Practices (GCP)
- Has
world-class Clinical Research Co-ordinators: Medical graduates
trained in GCP to assist the Principal Investigator complete
the clinical trials in a reliable and timely manner
- Has
33 clinical trial sites across 7 cities in the country
- Abides
by Neeman's execution process benchmarked to global standards
- Ensures
that resulting data is extremely high quality, which is
sine qua non of new drug registration and approval.
- Has
trained Institutional Review Board members as
accredited central lab facilities
- Has
a central pharmacy for storage of clinical trial supplies
- Has
the strength of English as the business language
Spectrum of Services
All
four phases of trials
- Bio-availability
and Bio-equivalence studies
- Trial
on herbal products
- Preparation
of study documents - Protocol, Case Report Form, Investigators
Brochure, Informed Consent Form
Clientele
Within
a short span of over two years, Neeman has built up reputation
capital and a client list that includes leaders of the industry.
30% of satisfied clients have asked Neeman to work with them
on further projects
For further information visit www.neeman-medical.com
|
| |
